OGAWA, H., NAGANO, H., KONNO, M., EGUCHI, H., KOSEKI, J., KAWAMOTO, K., . . . ISHII, H. (2015). The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer. Mol Clin Oncol.
استشهاد بنمط شيكاغوOGAWA, HISATAKA, et al. "The Combination of the Expression of Hexokinase 2 and Pyruvate Kinase M2 Is a Prognostic Marker in Patients With Pancreatic Cancer." Mol Clin Oncol 2015.
MLA استشهادOGAWA, HISATAKA, et al. "The Combination of the Expression of Hexokinase 2 and Pyruvate Kinase M2 Is a Prognostic Marker in Patients With Pancreatic Cancer." Mol Clin Oncol 2015.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.